199 research outputs found

    Molecular Mechanisms of Metformin for Diabetes and Cancer Treatment

    Get PDF
    Metformin has been the first-line drug treatment for hyperglycemia and insulin resistance for over 50 years. However, the molecular basis of its therapeutic role remained incompletely understood. Recent advances demonstrate that metformin could exert its glucose-lowering effect by multiple mechanisms, including activation of 5′-AMP-activated protein kinase, decreasing production of cyclic AMP, suppressing mitochondrial complex I of the electron transport chain, targeting glycerophosphate dehydrogenase, and altering the gut microbiome. In addition, epidemiological and clinical observation studies suggest that metformin reduced cancer risk in patients with type 2 diabetes and improved survival outcome of human cancers. Experimental studies have shown that this drug can inhibit cancer cell viability, growth, and proliferation through inhibiting mTORC1 signaling and mitochondrial complex I, suggesting that it may be a promising drug candidate for malignancy. Here, we summarize recent progress in studies of metformin in type 2 diabetes and tumorigenesis, which provides novel insight on the therapeutic development of human diseases

    Novel genetic reassortants in H9N2 influenza A viruses and their diverse pathogenicity to mice

    Get PDF
    <p>Abstract</p> <p>Background</p> <p>H9N2 influenza A viruses have undergone extensive reassortments in different host species, and could lead to the epidemics or pandemics with the potential emergence of novel viruses.</p> <p>Methods</p> <p>To understand the genetic and pathogenic features of early and current circulating H9N2 viruses, 15 representative H9N2 viruses isolated from diseased chickens in northern China between 1998 and 2010 were characterized and compared with all Chinese H9N2 viruses available in the NCBI database. Then, the representative viruses of different genotypes were selected to study the pathogenicity in mice with the aim to investigate the adaptation and the potential pathogenicity of the novel H9N2 reassortants to mammals.</p> <p>Results</p> <p>Our results demonstrated that most of the 15 isolates were reassortants and generated four novel genotypes (B62-B65), which incorporated the gene segments from Eurasian H9N2 lineage, North American H9N2 branch, and H5N1 viruses. It was noteworthy that the newly identified genotype B65 has been prevalent in China since 2007, and more importantly, different H9N2 influenza viruses displayed a diverse pathogenicity to mice. The isolates of the 2008-2010 epidemic (genotypes B55 and B65) were lowly infectious, while two representative viruses of genotypes B0 and G2 isolated from the late 1990s were highly pathogenic to mice. In addition, Ck/SD/LY-1/08 (genotype 63, containing H5N1-like NP and PA genes) was able to replicate well in mouse lungs with high virus titers but caused mild clinical signs.</p> <p>Conclusion</p> <p>Several lines of evidence indicated that the H9N2 influenza viruses constantly change their genetics and pathogenicity. Thus, the genetic evolution of H9N2 viruses and their pathogenicity to mammals should be closely monitored to prevent the emergence of novel pandemic viruses.</p

    Evaluating two concepts for the modelling of intermediates accumulation during biological denitrification in wastewater treatment

    Get PDF
    The accumulation of the denitrification intermediates in wastewater treatment systems is highly undesirable, since both nitrite and nitric oxide (NO) are known to be toxic to bacteria, and nitrous oxide (N2O) is a potent greenhouse gas and an ozone depleting substance. To date, two distinct concepts for the modelling of denitrification have been proposed, which are represented by the Activated Sludge Model for Nitrogen (ASMN) and the Activated Sludge Model with Indirect Coupling of Electrons (ASM-ICE), respectively. The two models are fundamentally different in describing the electron allocation among different steps of denitrification. In this study, the two models were examined and compared in their ability to predict the accumulation of denitrification intermediates reported in four different experimental datasets in literature. The N-oxide accumulation predicted by the ASM-ICE model was in good agreement with values measured in all four cases, while the ASMN model was only able to reproduce one of the four cases. The better performance of the ASM-ICE model is due to that it adopts an “indirect coupling” modelling concept through electron carriers to link the carbon oxidation and the nitrogen reduction processes, which describes the electron competition well. The ASMN model, on the other hand, is inherently limited by its structural deficiency in assuming that carbon oxidation is always able to meet the electron demand by all denitrification steps, therefore discounting electron competition among these steps. ASM-ICE therefore offers a better tool for predicting and understanding intermediates accumulation in biological denitrification

    PA-X is a virulence factor in avian H9N2 influenza virus

    Get PDF
    H9N2 influenza viruses have been circulating worldwide in multiple avian species, and regularly infect pigs and humans. Recently, a novel protein, PA-X, produced from the PA gene by ribosomal frameshifting, was demonstrated to be an antivirulence factor in pandemic 2009 H1N1, highly pathogenic avian H5N1 and 1918 H1N1 viruses. However, a similar role of PA-X in the prevalent H9N2 avian influenza viruses has not been established. In this study, we compared the virulence and cytopathogenicity of H9N2 WT virus and H9N2 PA-X-deficient virus. Loss of PA-X in H9N2 virus reduced apoptosis and had a marginal effect on progeny virus output in human pulmonary adenocarcinoma (A549) cells. Without PA-X, PA was less able to suppress co-expressed GFP in human embryonic kidney 293T cells. Furthermore, absence of PA-X in H9N2 virus attenuated viral pathogenicity in mice, which showed no mortality, reduced progeny virus production, mild-to-normal lung histopathology, and dampened proinflammatory cytokine and chemokine response. Therefore, unlike previously reported H1N1 and H5N1 viruses, we show that PA-X protein in H9N2 virus is a pro-virulence factor in facilitating viral pathogenicity and that the pro- or antivirulence role of PA-X in influenza viruses is virus strain-dependent

    Reliability and validity of the Chinese version of St Andrew′s Nutrition Screening Instrument

    Get PDF
    Objective·To translate St Andrew′s Nutrition Screening Instrument (SANSI), and test its reliability and validity.Methods·With the consent of the authors, the SANSI was translated into Chinese in accordance with the "Brislin translation-back translation method" and the Chinese version underwent cross-cultural debugging. Five clinical medical staff were selected to a pre-survey on 10 patients, and the expression and structure of the scale items were fine-tuned according to the feedback. A total of 221 inpatients with mental disorders were selected by convenient sampling method in Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine as research objects from January to February 2022, and the general clinical data of these patients were collected. The correlation between the items in Part Ⅲ and the identified risks in that part was evaluated by Spearman correlation analysis, and some items were deleted according to the results. Eight experts in mental disorders or nutrition were selected to evaluate the items of Chinese version of SANSI, and then the content validation indexes (CVIs) were calculated. With the standard of Nutritional Risk Screening 2002 (NRS2002), Spearman correlation analysis was used to evaluate the calibration validity of Chinese version of SANSI. Cronbach′s α coefficient, split half reliability and inter-rater reliability (κ consistency coefficient) were used to evaluate the reliability of the Part Ⅲ of the scale.Results·Through literal translation, back translation, cross-cultural debugging and pre-investigation, Chinese version of SANSI was formed. Among the 221 patients with mental disorders, 174 (78.73%) were males, the mean age was (64.12±13.87) years, and the duration of diseases was (26.06±17.65) years. There were 128 cases of schizophrenia (57.92%), 75 cases of organic mental disorders (33.94%), 10 cases of mood disorders (4.52%) and 8 cases of other mental disorders (3.62%). According to the results of correlation analysis in Part Ⅲ, the original items 1, 3, and 10 were deleted. The correlation coefficients between the remaining 7 items and the risk degree in this part were 0.391-0.734 (all P0.05).Conclusion·Chinese version of SANSI has good reliability and validity for hospitalized patients with mental disorders

    PPAR-α Agonist Fenofibrate Upregulates Tetrahydrobiopterin Level through Increasing the Expression of Guanosine 5′-Triphosphate Cyclohydrolase-I in Human Umbilical Vein Endothelial Cells

    Get PDF
    Tetrahydrobiopterin (BH4) is an essential cofactor for endothelial nitric oxide (NO) synthase. Guanosine 5′-triphosphate cyclohydrolase-I (GTPCH-I) is a key limiting enzyme for BH4 synthesis. In the present in vitro study, we investigated whether peroxisome proliferator-activated receptor α (PPAR-α) agonist fenofibrate could recouple eNOS by reversing low-expression of intracellular BH4 in endothelial cells and discussed the potential mechanisms. After human umbilical vein endothelial cells (HUVECs) were treated with lipopolysaccharide (LPS) for 24 hours, the levels of cellular eNOS, BH4 and cell supernatant NO were significantly reduced compared to control group. And the fluorescence intensity of intracellular ROS was significantly increased. But pretreated with fenofibrate (10 umol/L) for 2 hours before cells were induced by LPS, the levels of eNOS, NO, and BH4 were significantly raised compared to LPS treatment alone. ROS production was markedly reduced in fenofibrate group than LPS group. In addition, our results showed that the level of intracellular GTPCH-I detected by western blot was increased in a concentration-dependent manner after being treated with fenofibrate. These results suggested that fenofibrate might help protect endothelial function and against atherosclerosis by increasing level of BH4 and decreasing production of ROS through upregulating the level of intracellular GTPCH-I
    corecore